UCB Biopharma SRL clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
9 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 9 with minor changes only.
- Minor: Brivaracetam in Children and · Seizures Enrollment closed, study ongoing
- Minor: MyVisionXT · Rozanolixizumab · Ocular Myasthenia Gravis Trial sites expanded: 7 → 18 locations
- Minor: MyVision · Rozanolixizumab · Ocular Myasthenia Gravis Trial sites expanded: 29 → 36 locations
- Minor: SCALA · 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study · Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis Trial sites expanded: 23 → 26 locations
- Minor: ATMOS · 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study · Non-Cystic Fibrosis Bronchiectasis Trial sites expanded: 4 → 7 locations
- Minor: ziMyG · Subcutaneous Zilucoplan · Generalized Myasthenia Gravis Primary completion pushed from Nov 16, 2026 to May 12, 2027
- Minor: PHOENYCS FLY · Dapirolizumab Pegol in Study · Moderately to Severely Active Systemic Lupus Erythematosus Trial sites expanded: 242 → 245 locations
- Minor: Rozanolixizumab · Generalized Myasthenia Gravis Enrollment closed, study ongoing
- Minor: Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures Primary and study completion pushed from Oct 31, 2026 to Mar 29, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-13 | NCT07934472 A Study to Evaluate the Placental Transfer of Dapirolizumab Pegol to the Infant(s) From… | Phase 1 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 6 | |
| Phase 2 | 3 | |
| Phase 2/3 | 1 | |
| Phase 3 | 16 | |
| Phase 4 | 1 |
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Myasthenia Gravis (6) · Psoriasis (6) · Epilepsy (5) · Psoriatic Arthritis (4) · Lupus (SLE) (3) · Ankylosing Spondylitis (2) · Hidradenitis Suppurativa (2) · Atopic Dermatitis (1) · COPD (1)
Get alerts when UCB Biopharma SRL's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.